Skip to main content
Clinical Trials/NCT00639795
NCT00639795
Terminated
Not Applicable

Prospective Randomized Trial Evaluating the Effects of Paravertebral Nerve Blocks on Postoperative Pain and the Perioperative Inflammatory Response Following Video Assisted Thorascopic Surgery

Memorial Medical Center1 site in 1 country60 target enrollmentMarch 2008
ConditionsPain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain
Sponsor
Memorial Medical Center
Enrollment
60
Locations
1
Primary Endpoint
Comparing the degree of systemic post-operative inflammation with the degree of post-operative pain
Status
Terminated
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to compare:

  1. The degree of systemic postoperative inflammation (cytokine measurement) with the degree of post-operative pain
  2. The degree of pain and nausea and
  3. The pre and post operative pulmonary functions

following Video Assisted Thorascopic Surgery (VATS) performed under general anesthesia with the addition of intra-operative single-injection paravertebral blockade vs general anesthesia with a sham intra-operative paravertebral nerve blockade

Detailed Description

* Enrolled subjects scheduled to undergo video-assisted thorascopic surgery (VATS) will be randomized to receive either paravertebral block or placebo(adhesive bandage applied at the site). * All patients will undergo a standardized general anesthetic regimen. * Human biological specimens will be collected preoperatively, postoperatively (in the PACU) at the first morning blood draw of POD 1, POD 2, POD 3, and POD 10-14 (follow-up visit at surgeons office)and analyzed for CRP, Cortisol \& inflammatory markers (IL-1beta,IL-2,IL-4,IL-5,IL-6, IL-8, IL-10,INF-gamma, TNF-alpha) * Pulmonary functions (FEV1/FEV6) will be performed in the pre-op holding area prior to sedation and post-operatively on the morning of post-op day 1. * Pain levels will be assessed with the Wong-Baker Faces and Visual Analog Scale pre-operatively in the PACU and hourly for a total of 6 hours and then every 8 hrs.and with patient self-report in diary after discharge. * Pain levels will be assessed with the McGill-Melzack Pain Questionnaire pre-operatively, the evening of POD1-POD3 and by patient self-report in diary after discharge. * Nausea assessments will occur at arrival on floor and every 8 hours thereafter until discharge. * Narcotic requirements will be collected daily in the hospital and by patient self report in diary thereafter.

Registry
clinicaltrials.gov
Start Date
March 2008
End Date
March 2011
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age greater than 18
  • Planned thoracoscopy with low probability(by surgeon estimate) of conversion to open procedure

Exclusion Criteria

  • Age less than 18
  • Clinical or laboratory evidence of systemic infection
  • Current pregnancy as assessed by preoperative urine HCG test
  • Serious, uncontrolled, non-malignant illness
  • Malignant illness requiring systemic chemotherapy in the last 6 months
  • Documented allergy to oxycodone, morphine sulfate or acetaminophen
  • Contraindication to peripheral nerve blockade or general anesthesia including:
  • patient refusal
  • active infection at site of planned block
  • documented allergy to any local or general anesthetic medications

Outcomes

Primary Outcomes

Comparing the degree of systemic post-operative inflammation with the degree of post-operative pain

Time Frame: 1 year

Secondary Outcomes

  • To compare the degree of pain and nausea(1 year)

Study Sites (1)

Loading locations...

Similar Trials